<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38124254</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1468-2834</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Age and ageing</Title><ISOAbbreviation>Age Ageing</ISOAbbreviation></Journal><ArticleTitle>The role of multimorbidity and socio-economic characteristics as potential risk factors for Long Covid: evidence from the multilevel analysis of the Survey of Health, Ageing and Retirement in Europe's corona surveys (2020-2021).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">afad225</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ageing/afad225</ELocationID><Abstract><AbstractText Label="BACKGROUND">A substantial proportion of individuals continue experiencing persistent symptoms following the acute stage of their Covid-19 illness. However, there is a shortage of population-based studies on Long Covid risk factors.</AbstractText><AbstractText Label="OBJECTIVE">To estimate the prevalence of Long Covid in the population of middle-aged and older Europeans having contracted Covid-19 and to assess the role of multimorbidity and socio-economic characteristics as potential risk factors of Long Covid.</AbstractText><AbstractText Label="METHODS">A population-based longitudinal prospective study involving a sample of respondents 50 years and older (n&#xa0;=&#x2009;4,004) from 27 countries who participated in the 2020 and 2021 Survey of Health, Ageing and Retirement in Europe (SHARE), in particular the Corona Surveys. Analyses were conducted by a multilevel (random intercept) hurdle negative binomial model.</AbstractText><AbstractText Label="RESULTS">Overall, 71.6% (95% confidence interval&#x2009;=&#x2009;70.2-73.0%) of the individuals who contracted Covid-19 had at least one symptom of Long Covid up to 12 months after the infection, with an average of 3.06 (standard deviation&#x2009;=&#x2009;1.88) symptoms. There were significant cross-country differences in the prevalence of Long Covid and number of symptoms. Higher education and being a man were associated with a lower risk of Long Covid, whilst being employed was associated with a higher risk of having Long Covid. Multimorbidity was associated with a higher number of symptoms and older age was associated with a lower number of symptoms.</AbstractText><AbstractText Label="CONCLUSION">Our results provide evidence on the substantial burden of Long Covid in Europe. Individuals who contracted Covid-19 may require long-term support or further medical intervention, putting additional pressure on national health care systems.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilk</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Schulich School of Medicine &amp; Dentistry, Western University, London, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Living Conditions Department, Luxembourg Institute of Socio-Economic Research, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alperin</LastName><ForeName>Maria N Pi</ForeName><Initials>MNP</Initials><AffiliationInfo><Affiliation>Living Conditions Department, Luxembourg Institute of Socio-Economic Research, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohn</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7825-0697</Identifier><AffiliationInfo><Affiliation>Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagherazzi</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeegers</LastName><ForeName>Maurice P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MBP holding, Heerlen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Castell</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Living Conditions Department, Luxembourg Institute of Socio-Economic Research, Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN271201300071C</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052527</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG009740</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG005842</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG008291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 AG012815</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG025169</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG045301</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Age Ageing</MedlineTA><NlmUniqueID>0375655</NlmUniqueID><ISSNLinking>0002-0729</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055361" MajorTopicYN="N">Multilevel Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076322" MajorTopicYN="N">Multimorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ageing and Retirement in Europe (SHARE)</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Survey of Health</Keyword><Keyword MajorTopicYN="N">multilevel model</Keyword><Keyword MajorTopicYN="N">multimorbidity</Keyword><Keyword MajorTopicYN="N">older people</Keyword><Keyword MajorTopicYN="N">socio-economic factors</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>21</Day><Hour>0</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38124254</ArticleId><ArticleId IdType="pmc">PMC10733586</ArticleId><ArticleId IdType="doi">10.1093/ageing/afad225</ArticleId><ArticleId IdType="pii">7479753</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>

CSSE &#xa0;CfSSaE. COVID-19 Dashboard. Baltimore:
Johns Hopkins University; 2022. Available from: &#xa0;https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Chen &#xa0;C, Haupert &#xa0;SR, Zimmermann &#xa0;L, Shi &#xa0;X, Fritsche &#xa0;LG, Mukherjee &#xa0;B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis &#xa0;2022; 226: 1593&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney &#xa0;LL, Routen &#xa0;A, Gillies &#xa0;C &#xa0;et al. &#xa0;The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine &#xa0;2023; 55: 101762. 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano &#xa0;JB, Murthy &#xa0;S, Marshall &#xa0;JC, Relan &#xa0;P, Diaz &#xa0;JV, Condition WHOCCDWGoP-C-. &#xa0;A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis &#xa0;2022; 22: e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Han &#xa0;Q, Zheng &#xa0;B, Daines &#xa0;L, Sheikh &#xa0;A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens &#xa0;2022; 11: 269. 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson &#xa0;EJ, Williams &#xa0;DM, Walker &#xa0;AJ &#xa0;et al. &#xa0;Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun &#xa0;2022; 13: 3528. 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick &#xa0;JL, Titus &#xa0;AR, Slocum &#xa0;E &#xa0;et al. &#xa0;Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis &#xa0;2021; 73: 2055&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas &#xa0;C, Palacios-Cena &#xa0;D, Gomez-Mayordomo &#xa0;V &#xa0;et al. &#xa0;Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study. J Infect &#xa0;2021; 83: 237&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstrom &#xa0;B, Tao &#xa0;W. Social determinants of health and inequalities in COVID-19. Eur J Public Health. &#xa0;2020; 30: 617&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454505</ArticleId><ArticleId IdType="pubmed">32638998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mari-Dell'Olmo &#xa0;M, Gotsens &#xa0;M, Pasarin &#xa0;MI &#xa0;et al. &#xa0;Socioeconomic inequalities in COVID-19 in a European urban area: Two waves, two patterns. Int J Environ Res Public Health &#xa0;2021; 18: 1256. 10.3390/ijerph18031256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031256</ArticleId><ArticleId IdType="pmc">PMC7908269</ArticleId><ArticleId IdType="pubmed">33573323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena &#xa0;GE, Martinez &#xa0;PP, Mahmud &#xa0;AS, Marquet &#xa0;PA, Buckee &#xa0;CO, Santillana &#xa0;M. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science &#xa0;2021; 372: eabg5298. 10.1126/science.abg5298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg5298</ArticleId><ArticleId IdType="pmc">PMC8158961</ArticleId><ArticleId IdType="pubmed">33906968</ArticleId></ArticleIdList></Reference><Reference><Citation>Sese &#xa0;L, Nguyen &#xa0;Y, Giroux Leprieur &#xa0;E &#xa0;et al. &#xa0;Impact of socioeconomic status in patients hospitalised for COVID-19 in the Greater Paris area. Eur Respir J &#xa0;2020; 56: 2002364. 10.1183/13993003.02364-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02364-2020</ArticleId><ArticleId IdType="pmc">PMC7651837</ArticleId><ArticleId IdType="pubmed">33154032</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker &#xa0;M, Elliott &#xa0;J, Chadeau-Hyam &#xa0;M &#xa0;et al. &#xa0;Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun &#xa0;2022; 13: 1957. 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen &#xa0;N, Gurdasani &#xa0;D, O'Hara &#xa0;ME &#xa0;et al. &#xa0;Characteristics and impact of Long Covid: Findings from an online survey. PLoS One &#xa0;2022; 17: e0264331. 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsch-Supan &#xa0;A, Brandt &#xa0;M, Hunkler &#xa0;C &#xa0;et al. &#xa0;Data resource profile: The Survey of Health, Ageing and Retirement in Europe (SHARE). Int J Epidemiol &#xa0;2013; 42: 992&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780997</ArticleId><ArticleId IdType="pubmed">23778574</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;rsch-Supan &#xa0;A. &#xa0;Survey of health, ageing and retirement in Europe (SHARE) Wave 8. COVID-19 Survey 1. Release version: 8.0.0. SHARE-ERIC. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780997</ArticleId><ArticleId IdType="pubmed">23778574</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;rsch-Supan &#xa0;A. &#xa0;Survey of health, ageing and retirement in Europe (SHARE) Wave 9. COVID-19 Survey 2. Release version: 8.0.0. SHARE-ERIC. 2022.</Citation></Reference><Reference><Citation>Ma &#xa0;Y, Deng &#xa0;J, Liu &#xa0;Q, Du &#xa0;M, Liu &#xa0;M, Liu &#xa0;J. Long-term consequences of COVID-19 at 6 months and above: A systematic review and meta-analysis. Int J Environ Res Public Health &#xa0;2022; 19: 6865. 10.3390/ijerph19116865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116865</ArticleId><ArticleId IdType="pmc">PMC9180091</ArticleId><ArticleId IdType="pubmed">35682448</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter &#xa0;RS, Nieters &#xa0;A, Krausslich &#xa0;HG &#xa0;et al. &#xa0;Post-acute sequelae of covid-19 six to 12 months after infection: Population based study. BMJ &#xa0;2022; 379: e071050. 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman &#xa0;DE, Boudrias &#xa0;MH, Mazer &#xa0;B. Long COVID symptoms in a population-based sample of persons discharged home from hospital. Can J Public Health &#xa0;2022; 113: 930&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491248</ArticleId><ArticleId IdType="pubmed">36131218</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster &#xa0;C, Colombo &#xa0;MG, Wetzel &#xa0;AJ, Martus &#xa0;P, Joos &#xa0;S. Persisting symptoms after COVID-19. Dtsch Arztebl Int &#xa0;2022; 119: 167&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9215272</ArticleId><ArticleId IdType="pubmed">35236547</ArticleId></ArticleIdList></Reference><Reference><Citation>van den &#xa0;Akker &#xa0;M, Buntinx &#xa0;F, Knottnerus &#xa0;JA. Comorbidity or multimorbidity: What's in a name? A review of literature. Eur J General Practice &#xa0;1996; 2: 65&#x2013;70.</Citation></Reference><Reference><Citation>Fortin &#xa0;M, Stewart &#xa0;M, Poitras &#xa0;ME, Almirall &#xa0;J, Maddocks &#xa0;H. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med &#xa0;2012; 10: 142&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315131</ArticleId><ArticleId IdType="pubmed">22412006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullahy &#xa0;J. Specification and testing of some modified count data models. J Econometrics &#xa0;1986; 33: 341&#x2013;65.</Citation></Reference><Reference><Citation>Grogger &#xa0;JT, Carson &#xa0;RT. Models for truncated counts. J Appl Econometrics &#xa0;1991; 6: 225&#x2013;38.</Citation></Reference><Reference><Citation>Enders &#xa0;CK, Tofighi &#xa0;D. Centering predictor variables in cross-sectional multilevel models: A new look at an old issue. Psychol Methods &#xa0;2007; 12: 121&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">17563168</ArticleId></ArticleIdList></Reference><Reference><Citation>Little &#xa0;RJA, Rubin &#xa0;DB. Statistical Analysis with Missing Data, 2nd Edition. New York: John Wiley &amp; Sons; 2002. 10.1002/9781119013563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781119013563</ArticleId></ArticleIdList></Reference><Reference><Citation>SAS-Institute . SAS 9.4 Help and Documentation. Cary, NC: SAS Institute Inc., 2002-2022.</Citation></Reference><Reference><Citation>Muth&#xe9;n &#xa0;LK, Muth&#xe9;n &#xa0;BO. Mplus: Statistical Analysis with Latent Variables: User&#x2019;s Guide &#xa0;(Version 8):. Los Angeles: Muth&#xe9;n &amp; Muth&#xe9;n, 2022.</Citation></Reference><Reference><Citation>Ramos-Usuga &#xa0;D, Perrin &#xa0;PB, Bogdanova &#xa0;Y &#xa0;et al. &#xa0;Moderate, little, or no improvements in neurobehavioral symptoms among individuals with Long COVID: A 34-country retrospective study. Int J Environ Res Public Health &#xa0;2022; 19. 10.3390/ijerph191912593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912593</ArticleId><ArticleId IdType="pmc">PMC9564784</ArticleId><ArticleId IdType="pubmed">36231893</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Huang &#xa0;L, Wang &#xa0;Y &#xa0;et al. &#xa0;6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet &#xa0;2021; 397: 220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonsaksen &#xa0;T, Leung &#xa0;J, Price &#xa0;D &#xa0;et al. &#xa0;Self-teported Long COVID in the general population: Sociodemographic and health correlates in a cross-national sample. Life (Basel) &#xa0;2022; 12: 901. 10.3390/life12060901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12060901</ArticleId><ArticleId IdType="pmc">PMC9228837</ArticleId><ArticleId IdType="pubmed">35743932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>